Novacyt SA Revenue vs. Profit Margin

NVYTF Stock  USD 0.62  0.02  3.13%   
Based on the key profitability measurements obtained from Novacyt SA's financial statements, Novacyt SA may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Novacyt SA's ability to earn profits and add value for shareholders.
For Novacyt SA profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Novacyt SA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Novacyt SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Novacyt SA's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Novacyt SA over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Novacyt SA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novacyt SA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novacyt SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Novacyt SA Profit Margin vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Novacyt SA's current stock value. Our valuation model uses many indicators to compare Novacyt SA value to that of its competitors to determine the firm's financial worth.
Novacyt SA is regarded third in revenue category among its peers. It is regarded second in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novacyt SA's earnings, one of the primary drivers of an investment's value.

Novacyt Revenue vs. Competition

Novacyt SA is regarded third in revenue category among its peers. Market size based on revenue of Medical Devices industry is now estimated at about 1.37 Billion. Novacyt SA holds roughly 95.78 Million in revenue claiming about 7% of all equities under Medical Devices industry.
NVYTFBCCOYNVYTF7.0%TNON0.2%BCCOY92.0%ASAPF0.8%100%

Novacyt Profit Margin vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Novacyt SA

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
95.78 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Novacyt SA

Profit Margin

 = 

Net Income

Revenue

X

100

 = 
(0.1) %
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.

Novacyt Profit Margin Comparison

100%
Novacyt SA is currently under evaluation in profit margin category among its peers.

Novacyt SA Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Novacyt SA, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Novacyt SA will eventually generate negative long term returns. The profitability progress is the general direction of Novacyt SA's change in net profit over the period of time. It can combine multiple indicators of Novacyt SA, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Vlizy-Villacoublay, France. Novacyt operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 210 people.

Novacyt Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Novacyt SA. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Novacyt SA position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Novacyt SA's important profitability drivers and their relationship over time.

Use Novacyt SA in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Novacyt SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novacyt SA will appreciate offsetting losses from the drop in the long position's value.

Novacyt SA Pair Trading

Novacyt SA Pair Trading Analysis

The ability to find closely correlated positions to Novacyt SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Novacyt SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Novacyt SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Novacyt SA to buy it.
The correlation of Novacyt SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Novacyt SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Novacyt SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Novacyt SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Novacyt SA position

In addition to having Novacyt SA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Video Games Thematic Idea Now

Video Games
Video Games Theme
Companies that are involved in the building and marketing of video games or gaming software. The Video Games theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Video Games Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Novacyt Pink Sheet

To fully project Novacyt SA's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Novacyt SA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Novacyt SA's income statement, its balance sheet, and the statement of cash flows.
Potential Novacyt SA investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Novacyt SA investors may work on each financial statement separately, they are all related. The changes in Novacyt SA's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Novacyt SA's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.